MicroMed Cardiovascular Receives Approval For 5-Year CE Mark Extension Of DeBakey Ventricular Assist Device And Announces 400th Implant Of DeBakey VAD(R) System At Methodist HospitalM, Houston, Texas
HOUSTON, TX -- (MARKET WIRE) -- December 04, 2006 -- MicroMed Cardiovascular, Inc. (OTCBB: MMCV) received from its Notified Body, TUV, an approval extending the DeBakey VAD® system's CE Mark for an additional 5 years. The new European Union CE Mark is valid until April 27, 2011.